Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Common Stock | Award | $0 | +1.8K | +4.94% | $0.00 | 38.3K | Feb 8, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Stock Option (right to buy) | Award | $0 | +3.85K | $0.00 | 3.85K | Feb 8, 2024 | Common Stock | 3.85K | $31.89 | Direct | F2 |
Id | Content |
---|---|
F1 | The amount beneficially owned includes 13,900 restricted stock units (RSUs) that vest on service-based vesting dates and 14,941 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends. |
F2 | The stock options vest ratably on a monthly basis and become fully vested on February 8, 2025, the 12-month anniversary of the grant date. |